Exogenous insulin administration may help to counteract this condition and, it represents the primary and lifesaving treatment for T1D2 and is used in T2D when oral antidiabetic medications fail to achieve adequate glucose control3. The gene discussed is INS; the disease is type 2 diabetes mellitus.